Advanced Search:
Equity Index Forex Crypto Commodity

SNN - Smith & Nephew

$23.77  -0.75 (-3.06%)

Updated: 03:17 May 5, 2024 EST

Next Hour's AI Forecast

97.65%

Avg. Accuracy (AI)

$24.37

Next Session's AI Forecast

97.51%

Avg. Accuracy (AI)

$24.08

Next Week's AI Forecast

66.67%

Trend's Accuracy (AI)

$23.67

Smith & Nephew's Position Within the Medical Devices Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

SMITH & NEPHEW - HISTORICAL DATA 6M

  • Last price

    $ 23.77

  • Daily change

    $ -0.75

  • Previous Close

    $ 24.52

  • Last Updated

    03:17 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.84 0.06 -0.22 0.01 -0.1

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.92 1.33 1.21 1.1 1.09

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
91.18% 96.67% 95.15% 19.18%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
24.84 1.64% 24.44 -1.21% 24.74 -5.39% 26.15

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.4 56.33 1.75 28.57

Smith & Nephew Technical Analysis News

Smith & Nephew

Building 5
Croxley Park Hatters Lane
Watford WD18 8YE
United Kingdom
44 1923 477 100
https://www.smith-nephew.com

Sectors: Healthcare
Industry: Medical Devices
F. Time Employees: 18452
Description

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Corporate Governance

Smith & Nephew plc’s ISS Governance QualityScore as of May 1, 2024 is 9. The pillar scores are Audit: 5; Board: 2; Shareholder Rights: 9; Compensation: 10.

SMITH & NEPHEW'S HOLDERS RANK

List of holders with stock participation in Smith & Nephew.

Holder Rank Holder Shares Date Reported % Out Value